Science Daily: Pharmacology News
SEPTEMBER 23, 2024
With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
SEPTEMBER 23, 2024
Researchers explored the powerful effect of repetition on people's beliefs.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Collaborative Drug
SEPTEMBER 23, 2024
Learn how CDD Vault is utilizing AI to improve your drug discovery process.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Psilocybin, the active ingredient in magic mushrooms, appears to ease depression symptoms at least as well as one of the most commonly used antidepressants, a new clinical trial shows.Patients showed significant.
Collaborative Drug
SEPTEMBER 23, 2024
New Default ELN Editor: The new ELN editor that had been pre-released for testing is now the default editor for all newly created entries. You can continue to edit entries created with the previous editor, but new features will only be available in the new editor. Existing entries that are duplicated will continue to use the old editor. We recommend copying contents over to a new entry and taking advantage of the new templates feature.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- One in three former NFL players believe they have football-related brain damage that’s doing untold harm to their lives, a new study finds.Unfortunately, their fears might be harming their mental health on top of whatever r.
Collaborative Drug
SEPTEMBER 23, 2024
Upcoming Webinar 9-26-24: Generative Chemistry, Deep Learning and Traditional Models - Practical Insights and Emerging Technologies
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Antidepressants have the potential to improve memory and thinking skills, a new study suggests.Some patients experienced a boost on brain tests after taking the SSRI antidepressant escitalopram (Lexapro), researchers.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
Regulatory and strategic challenges can delay the delivery of life-changing cell and gene therapies.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Another health care worker who was exposed to a Missouri patient who tested positive for bird flu developed respiratory symptoms but wasn't tested for the flu, U.S. health officials reported Friday.The news is rekindling.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
GLP-1 drugs went from helping with blood sugar management to supporting weight loss. What’s next?
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Kids born during the first year of the COVID-19 pandemic appear to have no higher risk of autism, even if they were exposed to COVID in the womb, a new study finds.The study offers reassurance to doctors and parents who’ve.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
The company’s technology, which enables it to target viral proteins in their “prefusion” shape and skip a manufacturing step, could lead to vaccines that are more potent and easier to produce, said CEO Emmanuel Hanon.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Having a husband or boyfriend with adult ADHD can harm a woman's mental stability, a new study suggests.About 3 in 5 women (59%) with male partners with attention-deficit/hyperactivity disorder (ADHD) had symptoms of.
Science Daily: Pharmacology News
SEPTEMBER 23, 2024
Knowing how animals use their environments to survive and thrive is a key challenge for predicting how global climate change will affect wildlife. A global collaborative study of four species of crane has shed light on the way that migrations are finely tuned to unpredictable and complex environments. A team from 10 countries combined novel animal tracking technology, remote-sensed information about the environment, and a new statistical framework to gain insight into four iconic species: common
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Research in rats and hibernating squirrels has pinpointed a naturally occurring protein that appears to reverse cataracts, scientists report.Animal studies don't always pan out in people, of course. But the discovery of.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
The partners said their antibody-drug conjugate datopotomab deruxtecan didn’t extend survival in a breast cancer study, fueling additional doubts about its approval prospects.
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Diabetes can worsen the state of your gums, but a new study suggests that diabetes medications may undo some of that damage. Researchers in Japan found a positive turnaround in markers of gum well-being after people with.
BioPharma Drive: Drug Pricing
SEPTEMBER 23, 2024
Dr. Meg Richards from Panalgo discusses how real-world data is unlocking advancements in drug safety during pregnancy.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
SEPTEMBER 23, 2024
MONDAY, Sept. 23, 2024 -- Kidney stone fragments sometimes just need a little push to be flushed out of a person’s system, a new trial finds.About seven in 10 patients who got ultrasound treatment to encourage fragments to clear from their kidneys w.
Drug Patent Watch
SEPTEMBER 23, 2024
The generic drug market has experienced significant growth over the past few decades, driven by the expiration of patents on branded drugs and the increasing demand for affordable healthcare solutions. However, the industry faces several challenges, including commoditization, regulatory hurdles, and intense competition.
Quanticate
SEPTEMBER 23, 2024
SAS® (Statistical Analysis System) is a powerful tool widely used in clinical programming, data analysis, and reporting. Whether you’re working on clinical trials or handling complex data analyses, mastering SAS® programming techniques and managing large datasets efficiently are crucial for successful outcomes. In this article, we’ll explore our top 5 SAS® tips and tricks, key SAS® techniques that enhance coding efficiency, and delve into best practices for handling large datasets.
Perficient: Drug Development
SEPTEMBER 23, 2024
Perficient is happy to announce that Consulting Magazine recently recognized Rupa Amin and Lina Maria Jaramillo Lopera in the 2024 Women Leaders in Consulting Awards. The awards program seeks to recognize women within the consulting industry who demonstrate excellence in their work and who are making an impact. Rupa and Lina were chosen because they embody the characteristics and leadership qualities that make a difference in the industry and pave the way for future women leaders.
FDA Law Blog: Biosimilars
SEPTEMBER 23, 2024
By Kurt R. Karst — Forty years ago today—on a sunny Monday, September 24, 1984 at approximately 3:30 PM Eastern Time in the Rose Garden at the White House—President Ronald Reagan signed into law Public Law 98-417 , the Drug Price Competition and Patent Term Restoration Act of 1984, stating that “[t]he legislation will speed up the process of Federal approval of inexpensive generic versions of many brand name drugs, make the generic versions more widely available to consumers, and grant pharmaceu
Perficient: Drug Development
SEPTEMBER 23, 2024
In an increasingly digital world, ensuring that everyone can access and enjoy online content is more important than ever. This is where Universal Design comes into play in the healthcare system, aiming to create products and environments that are usable by all people, to the greatest extent possible, without the need for adaptation or specialized design.
Crown Bioscience
SEPTEMBER 23, 2024
Patient-derived xenograft (PDX) models have become a cornerstone in cancer research, offering valuable insights into tumor biology and drug efficacy. However, recent studies have uncovered significant quality issues that threaten the reliability of these models. As researchers, we must be aware of these challenges to ensure the validity of our findings.
Broad Institute
SEPTEMBER 23, 2024
About MIA By nkarpova@broadinstitute.org September 23, 2024 Breadcrumb Home MIA About MIA Follow MIA on Twitter and on the Schmidt Center LinkedIn. MIA weekly meetings feature a primer, breakfast, seminar, and discussion; these meetings are interactive and have a pedagogical focus. Instead of an emphasis on research results, speakers dive into the methods — their mechanics, intuition, and philosophy — in the context of their research, so that participants can leave the talk having absorbed new i
Expert insights. Personalized for you.
326 
Let's personalize your content